evans blue has been researched along with Encephalopathy, Toxic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ding, J; Fan, H; Gu, C; He, Y; Huang, J; Li, Y; Qi, X; Qiu, P; Wang, X; Wang, Z; Xie, Q | 1 |
Fujii, M; Fujisawa, H; Goto, H; Kajiwara, K; Kato, S; Maekawa, T; Nomura, S; Oka, F; Suzuki, M | 1 |
2 other study(ies) available for evans blue and Encephalopathy, Toxic
Article | Year |
---|---|
Transfer of neuron-derived α-synuclein to astrocytes induces neuroinflammation and blood-brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1.
Topics: alpha-Synuclein; Astrocytes; Blood-Brain Barrier; Central Nervous System Stimulants; Endothelial Cells; Evans Blue; Fluorescein; Glial Cell Line-Derived Neurotrophic Factor; Humans; Immunoglobulin G; Interleukin-6; Methamphetamine; Neuroinflammatory Diseases; Neurons; Neurotoxicity Syndromes; Occludin; Receptors, Cytoplasmic and Nuclear; Tumor Necrosis Factor-alpha | 2022 |
Neurotoxic effects of exogenous recombinant tissue-type plasminogen activator on the normal rat brain.
Topics: Animals; Blood Gas Analysis; Blood Pressure; Blood-Brain Barrier; Body Temperature; Brain; Brain Edema; Cell Death; Coloring Agents; Evans Blue; Extracellular Space; Hydrogen-Ion Concentration; Immunohistochemistry; Laminin; Male; Neurotoxicity Syndromes; Rats; Rats, Wistar; Recombinant Proteins; Tissue Plasminogen Activator | 2007 |